Bankrupt DNA testing company 23andMe Holding (OTC:MEHCQ) is set to hold a second auction to sell its assets, including ...

Me wants to reopen bidding on its assets after former CEO Anne Wojcicki put together a $305 million offer, topping Regeneron.

Added to that, 23andMe suffered a massive data breach in 2023 that resulted in information from about 7 million people being ...

The fate of genetic data belonging to millions of 23andMe customers is again up in the air, as the bankrupt company seeks a judge’s permission to consider another bid from its co-founder and ...

Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...

The move marks a turning point in 23andMe’s tumultuous decline. Founded in 2006 by Wojcicki, the company initially gained traction with its saliva-based ancestry kits and went public in 2021. By the ...

Nice 23andMe sale hearing ya got there — shame if something happened to it, say attorneys for co-founder and former CEO who ...

From Nvidia to Airbnb, many of today’s top-performing companies are led by founders who’ve stayed in power for over a decade.

The offer is nearly $50 million more than the last bid from Regeneron Pharmaceuticals, which had been declared the winner of the first auction last month, only to have the outcome challenged in ...

The founder of 23andMe, Anne Wojcicki, has asked a federal bankruptcy court judge to reopen an auction for the genetic ...

after a group led by its former CEO Anne Wojcicki submitted a $305M bid, beating an initial $256M offer from Regeneron (NASDAQ:REGN). Following its Chapter 11 filing in a Missouri bankruptcy court ...